Side-effect and vital sign profile of nifedipine as a tocolytic for preterm labour

Hong Kong Medical Journal

Volumn 14, Issue 4, 2008, Pages 267-272

  Chan, L W ^a   Sahota, D S ^a   Yeung, S Y ^a   Leung, T Y ^a   Fung, T Y ^a   Lau, T K ^a   Leung, T N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Nifedipine; Obstetric labor, premature; Tocolysis

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DEXAMETHASONE; NIFEDIPINE; SULINDAC; UTERUS SPASMOLYTIC AGENT;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE; DIZZINESS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FETUS HEART RATE; FLUSHING; HEADACHE; HEART RATE; HONG KONG; HUMAN; HYPOTENSION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; NAUSEA; PATIENT ASSESSMENT; PATIENT MONITORING; PREMATURE LABOR; QUESTIONNAIRE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SIDE EFFECT; TACHYCARDIA; TERTIARY HEALTH CARE; TREATMENT FAILURE; VITAL SIGN;

ADMINISTRATION, SUBLINGUAL; ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL MONITORING; FOLLOW-UP STUDIES; GESTATIONAL AGE; HEART RATE; HEART RATE, FETAL; HOSPITALS, UNIVERSITY; HUMANS; MONITORING, PHYSIOLOGIC; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TOCOLYTIC AGENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 49449094164     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nakajima H, Hoshiyama M, Yamashita K, Kiyomoto A. Effect of diltiazem on electrical and mechanical activity of isolated cardiac ventricular muscle of guinea pig. Jpn J Pharmacol 1975;25:383-92.
2. Braunwald E. Mechanism of action of calcium-channel-blocking agents. N Engl J Med 1982;307:1618-27.
3. Ulmsten U, Andersson KE, Forman A. Relaxing effects of Nifedipine on the nonpregnant human uterus in vitro and in vivo. Obstet Gynecol 1978;52:436-41.
4. Ulmsten U, Andersson KE, Wingerup L. Treatment of premature labor with the calcium antagonist nifedipine. Arch Gynecol 1980;229:1-5.
5. Clinical Guideline No. 1(B). Tocolytic drugs for women in preterm labour. London: Royal College of Obstetricians and Gynaecologists; 2002.
6. King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003;(1):CD002255.
7. Oei SG. Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events. Eur J Obstet Gynecol Reprod Biol 2006;126:137-45.
8. Papatsonis DN, Van Geijn HP, Adèr HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997;90:230-4.
9. Murdoch D, Brogden RN. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders. Drugs 1991;41:737-79. Erratum in: Drugs 1991;42:330.
10. Thornton J. The drugs we deserve. BJOG 2003;110:969-70.
11. Papatsonis DN, Flenady VJ, Dekker GA, Carbonne B, King JF. Response to "The drugs we deserve". BJOG 2004;111:1025.
12. Jones B, Mohan A, Bennett P. The drugs we deserve. BJOG 2004;111:392-3.
13. Ferguson JE 2nd, Schutz T, Pershe R, Stevenson DK, Blaschke T. Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol 1989;161:1485-90.
14. Manninen AK, Juhakoski A. Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring. Int J Clin Pharmacol Res 1991;11:231-6.
15. Carbonne B, Papatsonis DN, Flenady VJ, Dekker GA, King JF. Comment on the article "Acute pulmonary oedema during nicardipine therapy for premature labour. Report of five cases" by Vaast P., et al. [Eur J Obstet Gynecol Reprod Biol 2004;113:98-9]. Eur J Obstet Gynecol Reprod Biol 2005;120:119.